PlantForm Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $25M

  • Investors
  • 10

PlantForm General Information

Description

Developer of antibody and protein drugs designed to assist in cancer treatment. The company's products use mammalian and bacterial cell culture systems to produce recombinant protein pharmaceuticals including monoclonal antibodies, therapeutic proteins and vaccines, enabling physicians to treat cancer, Ebola virus and other life-threatening illnesses.

Contact Information

Website
www.plantformcorp.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
+1 (416) 000-0000
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1920 Yonge Street
  • Suite 200
  • Toronto, Ontario M4S 3E2
  • Canada
+1 (416) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlantForm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC $25M Upcoming Generating Revenue
12. Grant 27-Feb-2018 0000 00.00 Completed Generating Revenue
11. Grant 12-Dec-2016 00000 00.00 Completed Generating Revenue
10. Grant 04-Jan-2016 00.00 Completed Generating Revenue
9. Grant 28-Oct-2015 00000 00.00 Completed Generating Revenue
8. Grant 31-Mar-2015 00000 00.00 Completed Generating Revenue
7. Grant 22-Dec-2014 00.00 Completed Generating Revenue
6. Grant 16-May-2014 0000 00.00 Completed Generating Revenue
5. Later Stage VC 20-Aug-2013 $2M $3.5M 0000 Completed Clinical Trials - Phase 1
4. Grant 12-Aug-2013 $2.26M $1.5M Completed Startup
To view PlantForm’s complete valuation and funding history, request access »

PlantForm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody and protein drugs designed to assist in cancer treatment. The company's products use mammalian and
Drug Discovery
Toronto, Canada
25 As of 2024
00.00
00000 00000

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000 000000000
Boston, MA
0000 As of 0000
00.000
0000 0000-00-00
000000&0

000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
0000 000000000
Marina del Rey, CA
00 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PlantForm Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vertex Pharmaceuticals Formerly VC-backed Boston, MA 0000 00.000 000000&0
Armata Pharmaceuticals Formerly VC-backed Marina del Rey, CA 00 00000 000000000000 00000
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland 000 00000 000000000 00000
Atomwise Venture Capital-Backed San Francisco, CA 00 00000 00000000000 00000
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
You’re viewing 5 of 21 competitors. Get the full list »

PlantForm Patents

  • 15

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 11

    Pending

  • 000

    Expiring in next 12 mo

PlantForm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3179142-A1 Production of ace2-fc fusion protein in plants and uses thereof Pending 13-Oct-2021
CA-3132423-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000
EP-3935180-A4 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000 0
EP-3935180-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 00000000000
US-20220135992-A1 T-dna vectors with engineered 5' sequences upstream of post-translational modification enzymes and methods of use thereof Pending 06-Mar-2019 C12N15/8257
To view PlantForm’s complete patent history, request access »

PlantForm Executive Team (6)

Name Title Board Seat
Donald Stewart Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Ronald Hosking Co-Founder, Chief Financial Officer & Chairman
David Cayea Chief Operating Officer
Mark Goldberg Ph.D Co-Founder & Board Member
You’re viewing 4 of 6 executive team members. Get the full list »

PlantForm Board Members (9)

Name Representing Role Since
Bruce Clark Ph.D Self Board Member 000 0000
David Fraser Self Board Member 000 0000
Donald Stewart Ph.D PlantForm Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Mark Goldberg Ph.D PlantForm Co-Founder & Board Member 000 0000
Michael Wanner Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

PlantForm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PlantForm Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Natural Sciences and Engineering Research Council of Canada Government 000 0000 000000 0
NSERC-Engage Government 000 0000 000000 0
Government of Canada Government 000 0000 000000 0
Atlantic Assets Trust Corporation Minority 000 0000 000000 0
Defense Advanced Research Projects Agency Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

PlantForm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PlantPraxis 01-Jan-2014 00000 0000 Biotechnology
To view PlantForm’s complete investments history, request access »

Ready to get started?

Request a free trial

PlantForm FAQs

  • When was PlantForm founded?

    PlantForm was founded in 2008.

  • Who is the founder of PlantForm?

    Donald Stewart Ph.D, Ronald Hosking, J. Hall Ph.D, and Mark Goldberg Ph.D are the founders of PlantForm.

  • Who is the CEO of PlantForm?

    Donald Stewart Ph.D is the CEO of PlantForm.

  • Where is PlantForm headquartered?

    PlantForm is headquartered in Toronto, Canada.

  • What is the size of PlantForm?

    PlantForm has 25 total employees.

  • What industry is PlantForm in?

    PlantForm’s primary industry is Drug Discovery.

  • Is PlantForm a private or public company?

    PlantForm is a Private company.

  • What is PlantForm’s current revenue?

    The current revenue for PlantForm is 00000.

  • How much funding has PlantForm raised over time?

    PlantForm has raised $3.5M.

  • Who are PlantForm’s investors?

    Natural Sciences and Engineering Research Council of Canada, NSERC-Engage, Government of Canada, Atlantic Assets Trust, and Defense Advanced Research Projects Agency are 5 of 10 investors who have invested in PlantForm.

  • Who are PlantForm’s competitors?

    Vertex Pharmaceuticals, Armata Pharmaceuticals, CRISPR Therapeutics, Atomwise, and Genentech are some of the 21 competitors of PlantForm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »